Skip to content

To test the efficacy of Syrup Oligomenorrhea

An Open Label, Single Arm Clinical Study to Evaluate the safety and efficacy of Gyno Shudhhi Syrup in patients suffering from Oligomenorrhea - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080353
Enrollment
40
Registered
2025-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Gyno Shudhhi Syrup: Route: Oral, Dosage Form: Kwatha/Kashaya, Dose: 10(ml), Frequency: tid, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information:

Sponsors

Jeena Sikho Lifecare Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Females from 18 to 45 years of age. 2.Females suffering from Oligomenorrhea. 3.If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study. 4.Females that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 5.Females willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Females that are pregnant, breast feeding, or planning to get pregnant during the study. 2.Females that have participated in any other interventional clinical trial in the previous 90 days. 3.Females with known sensitivity to any of the constituents of the investigational product.

Design outcomes

Primary

MeasureTime frame
Efficacy of Gyno Shudhhi Syrup 1. Change in the SGA Score 2. Change in the LH range 3. Change in the FSH range 4. Change in the LH/FSH Ratio range Timepoint: Day 1, Day 30, Day 60 and Day 90

Secondary

MeasureTime frame
Change in QOLTimepoint: Day 1, Day 30, Day 60 and Day 90

Countries

India

Contacts

Public ContactPuneet Mittal

MGCTS(Mittal Global Clinical Trial Services)

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026